|
Friedman, Michael A.
Served in the U.S. National Institutes of Health's National Cancer Institute as chief of the Clinical Investigations Branch of the Division of Cancer Treatment (1983-?) and as associate director of the Cancer Therapy Evaluation Program (1988-95). (1)
U.S. Food & Drug Administration's Acting Commissioner (1997-98).
Reservist in the Public Health Service.
G. D. Searle & Co. (Monsanto subsidiary) senior vice president for clinical affairs (1999-?).
Pharmacia Corporation senior vice president (Pharmacia was acquired by Pfizer in 2003).
Pharmaceutical Research and Manufacturers of America (PhRMA) chief medical officer for biomedical preparedness (2001-03).
President and chief executive officer of City of Hope, a biomedical research and treatment institute (beginning in 2003).
Elected to board of Rite Aid in 2004 (term to expire in 2005).
Endnotes:
(1) Rite Aid news release, Oct 8, 2004 at http://www.riteaid.com/company_info/press/press_show.php/item_nbr/650/cat/national , accessed Jan 16, 2005
|
